• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Natural Alternatives International Inc.

    1/21/26 1:21:12 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $NAII alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 12)


    Natural Alternatives International Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    638842302

    (CUSIP Number)


    12/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    638842302


    1Names of Reporting Persons

    Dimensional Fund Advisors LP
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    379,548.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    384,497.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    384,497.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.2 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Natural Alternatives International Inc
    (b)Address of issuer's principal executive offices:

    1185 Linda Vista Drive, San Marcos, CA 92078
    Item 2. 
    (a)Name of person filing:

    Dimensional Fund Advisors LP
    (b)Address or principal business office or, if none, residence:

    6300 Bee Cave Road, Building One, Austin, TX 78746
    (c)Citizenship:

    Delaware Limited Partnership
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    638842302
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    384,497 ** see Note 1 ** ** Note 1 ** Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts (such investment companies, trusts and accounts, collectively referred to as the "Funds"). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, "Dimensional") may possess voting and/or investment power over the securities of the Issuer that are owned by the Funds, and may be deemed to be the beneficial owner of the shares of the Issuer held by the Funds. However, all securities reported in this schedule are owned by the Funds. Dimensional disclaims beneficial ownership of such securities. In addition, the filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this Schedule 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934.
    (b)Percent of class:

    6.2  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    379,548** see Note 1 **

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    384,497** see Note 1 **

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Funds described in Note 1 above have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the securities held in their respective accounts. To the knowledge of Dimensional, the interest of any one such Fund does not exceed 5% of the class of securities. Dimensional Fund Advisors LP disclaims beneficial ownership of all such securities.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Dimensional Fund Advisors LP
     
    Signature:Selwyn Notelovitz
    Name/Title:Global Chief Compliance Officer
    Date:01/21/2026
    Get the next $NAII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NAII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NAII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO/Chairman Ledoux Mark A gifted 10,000 shares, decreasing direct ownership by 6% to 150,221 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    1/5/26 3:09:27 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Dunn Alan G was granted 8,000 shares, increasing direct ownership by 10% to 91,211 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:16:26 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Ramanathan Guru was granted 8,000 shares, increasing direct ownership by 36% to 30,000 units (SEC Form 4)

    4 - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Issuer)

    3/11/25 5:15:28 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Natural Alternatives International Inc.

    SCHEDULE 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    1/21/26 1:21:12 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    12/17/25 5:13:44 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Filer)

    12/11/25 8:10:35 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natural Alternatives International, Inc. Announces 2026 Q1 Results

    CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2025, increased $4.6 million, or 13.8%, to $37.7 million as compared to $33.2 million recorded in the comparable prior year period. During the same period, private-label contract m

    11/12/25 4:44:13 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results

    CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1.20) per diluted share, on net sales of $33.9 million for the fourth quarter of fiscal year 2025 compared to a net loss of $1.9 million, or ($0.32) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2025 included non-recurring non-cash charges of $1.4 million related to the settlement of a litigation matter and a $4.8 million valuation allowance against our net deferred tax asse

    9/23/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company

    CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company ("Juice Plus+"), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world. Mark A. LeDoux, NAI's CEO and Chairman of the Board, said, "Continuing our 30+ year relationship with JuicePlus+ reflects our shared commitment to delivering premium nutrit

    7/21/25 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Leadership Updates

    Live Leadership Updates

    View All

    Natural Alternatives International Appoints New VP of Global Sales

    CARLSBAD, Calif., July 25, 2023 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII) ), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced that sales executive Shane Conti has joined the company as the Vice President of Global Sales and will be a key driver of global expansion and growth. Over the course of his 25 plus year career in the domestic and international nutritional supplement industry, Conti has established a proven track record of success in building new business within multiple markets. "Shan

    7/25/23 9:00:00 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    NATURAL ALTERNATIVES INTERNATIONAL APPOINTS AARON STARR VICE PRESIDENT FOR CARNOSYN® BRANDS

    CARLSBAD, Calif., April 21, 2022 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, announced Aaron Starr has been promoted to Vice President of CarnoSyn® Brands. In his new role, Starr will be responsible for the leadership of business teams and for overseeing operational performance and the advancement of CarnoSyn® Brands. "I am pleased to announce Aaron Starr has been named Vice President of CarnoSyn® Brands," said Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International. "Aaron has been a valued member of our team for many year

    4/21/22 5:00:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Neptune Wellness Appoints Randy Weaver as Interim Chief Financial Officer and Retains Dr. Toni Rinow as Chief Operating Officer

    LAVAL, QC, Sept. 27, 2021 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ:NEPT) (TSX:NEPT), a diversified and fully integrated health and wellness company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced the appointment of Randy Weaver as Interim Chief Financial Officer while retaining Dr. Toni Rinow as Chief Operating Officer. Mr. Weaver joins Neptune as Interim Chief Financial Officer with a successful track record of leading numerous CPG companies as a senior executive, bringing the knowledge and e

    9/27/21 7:30:00 AM ET
    $NAII
    $NEPT
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $NAII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/13/24 10:37:08 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/9/24 9:59:14 AM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Natural Alternatives International Inc. (Amendment)

    SC 13G/A - NATURAL ALTERNATIVES INTERNATIONAL INC (0000787253) (Subject)

    2/5/24 8:25:38 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    $NAII
    Financials

    Live finance-specific insights

    View All

    Natural Alternatives International, Inc. Announces 2022 Q1 Results

    CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ -- -Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.3 million, or $0.51 per diluted share, on net sales of $38.3 million for the first quarter of fiscal year 2022 compared to net income of $2.3 million, or $0.35 per diluted share, in the first quarter of the prior fiscal year.  Net sales during the three months ended September 30, 2021 decreased $1.4 million, or 3.5%, to $38.3 million as compared to $39.7 million recorded in the comparable prior year period.  During the same period, private-label contract man

    11/9/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care

    Natural Alternatives International, Inc. Announces 2021 Q3 and YTD Results

    CARLSBAD, Calif., May 13, 2021 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $1.9 million, or $0.30 per diluted share, on net sales of $46.3 million for the third quarter of fiscal year 2021 compared to a net loss of $4.0 million, or $0.61 per diluted share, in the third quarter of the prior fiscal year.  Our results for the third quarter of fiscal 2020 included the negative impact of a $4.3 million accounts receivable and inventory reserve related to a former customer, which was not repeated in the third quarter of fiscal 2021.  Net s

    5/13/21 4:30:00 PM ET
    $NAII
    Medicinal Chemicals and Botanical Products
    Health Care